Prelude Capital Management, LLC Covetrus, Inc. Transaction History

Prelude Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$20.69 - $20.91 $907,628 - $917,279	43,868 Added 24.35%	223,997 $4.68 Million
Q2 2022 Aug 15, 2022	BUY	$13.8 - $20.82 $2.49 Million - $3.75 Million	180,129 New	180,129 $3.74 Million
Q1 2022 May 16, 2022	SELL	$15.96 - $18.87 $373,368 - $441,444	-23,394 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$16.79 - $20.37 $392,785 - $476,535	23,394 New	23,394 $467,000
Q4 2020 Feb 16, 2021	SELL	$24.45 - $31.59 $111,687 - $144,303	-4,568 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.22 - $24.59 $14,585 - $20,827	847 Added 22.76%	4,568 $111,000
Q2 2020 Aug 14, 2020	BUY	$6.46 - $19.27 $24,037 - $71,703	3,721 New	3,721 $67,000
Q1 2020 May 15, 2020	SELL	$5.64 - $15.23 $1,940 - $5,239	-344 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.8 - $14.93 $3,027 - $5,135	344 New	344 $5,000

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.